Stay updated on Avelumab in Chemo-resistant GTN Clinical Trial
Sign up to get notified when there's something new on the Avelumab in Chemo-resistant GTN Clinical Trial page.

Latest updates to the Avelumab in Chemo-resistant GTN Clinical Trial page
- CheckyesterdayChange Detected- Revision tag updated from v3.4.3 to v3.5.0, indicating a minor update. No changes to study details or eligibility information were observed.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedRevision label updated to v3.4.2 (replacing v3.4.1); no study details, eligibility criteria, results, or other core content were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 removed. This is a minor frontend labeling change with no impact on study details.SummaryDifference0.1%

- Check51 days agoChange DetectedUI text updates include adding a 'Show glossary' option and a new 'Revision: v3.4.0' tag, plus minor capitalization changes such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', while the older phrasing 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now displays Last Update Posted and Revision: v3.3.4, and Last Update Posted (Estimated) and Revision: v3.3.3 were removed.SummaryDifference0.1%

Stay in the know with updates to Avelumab in Chemo-resistant GTN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab in Chemo-resistant GTN Clinical Trial page.